Topics
Research & Innovation
-
Tuesday - July 29, 2008
New markets
Bayer Technology Services and Xytel market microreaction technology
Flexible and high performance pilot plants for the oil & gas, chemical and pharmaceutical industries
-
Thursday - July 10, 2008
Overcoming boundaries:
Geri Winkler becomes the first diabetic to conquer the Seven Summits
Adventurer reaches the peak of Mount McKinley (Denali) in Alaska
-
Friday - June 27, 2008
Bayer at a glance:
New edition of “Names, Figures, Facts”
Service line for free booklet
-
Monday - June 23, 2008
New Bayer technology reduces power consumption and CO2 emissions by 30 percent:
Bayer receives Environmental Award from the Federation of German Industries
Energy-efficient process recycles chlorine from hydrochloric acid / Industrial application in Germany and China / Bayer Management Board member Dr. Plischke: “Increase in energy efficiency brings economic and ecological benefits”
-
Monday - June 16, 2008
Inauguration of Bayer’s pilot facility for the “production of medicinal products in tobacco plants”
Halle, Germany
-
Monday - June 16, 2008
Pilot plant for future-oriented technology opens in Halle:
Bayer will use tobacco plants to produce medicines
First development candidate from the new plant for cancer indication non-Hodgkin’s lymphoma – Clinical phase I could start in 2009 / Bayer has invested over EUR 10 million in Halle since 2006
-
Monday - June 16, 2008
Inauguration of Bayer’s pilot facility for the “production of medicinal products in tobacco plants” Halle, Germany
Address by Dr. Wolfgang Plischke
Member of the Management Board of Bayer AG
-
Monday - June 16, 2008
Inauguration of Bayer’s pilot facility for the “production of medicinal products in tobacco plants” Halle, Germany
Address by Prof. Dr. Yuri Gleba
Managing Director of Icon Genetics AG
-
Monday - June 16, 2008
About Non-Hodgkin’s Lymphoma and Idiotype Vaccination
-
Monday - June 16, 2008
Bayer CropScience opens rice research laboratory in Singapore
Investment of EUR 5 million to support development of new rice varieties for the Asian market
-
Friday - May 30, 2008
Prevention of Thromboembolism after Knee Replacement Surgery:
Rivaroxaban One Tablet/Once-Daily Superior to Twice-Daily Injectable Enoxaparin in Preventing Venous Blood Clots after Total Knee Replacement Surgery in Pivotal Phase III Trial
Rivaroxaban is First Oral Anticoagulant to Achieve Superior Efficacy over the Twice-Daily Injection of Enoxaparin while Maintaining Low Major Bleeding Rates / RECORD4 Confirms Results of RECORD1, 2 and 3 / U.S. Submission Planned for mid 2008 / Prof. Turpie: “Rivaroxaban has the potential to revolutionize the way we prevent the formation of dangerous blood clots”
-
Monday - May 19, 2008
Amikacin Inhale shows promising results in Phase II Study
Bayer together with Nektar Therapeutics present preliminary Phase II data for the adjunctive treatment of pneumonia in intubated and mechanically-ventilated patients
-
Monday - May 19, 2008
Bayer Climate Program
Bayer Climate Check certified by TÜV Süd
Innovative control instrument for climate-friendly production processes
-
Wednesday - May 7, 2008
IFAT 2008
Wastewater treatment process "made by Bayer"
Bayer Technology Services presents proven environmental protection technologies at the leading international trade fair for the environmental sector.
-
Monday - April 21, 2008
HANNOVER FAIR/INTERKAMA+
Bayer Technology Services presents innovative optimization and identification technologies
Operational Excellence can significantly enhance productivity / Complete range of identification technologies / Bayer Climate Check: Tool for the reduction of CO2 emissions
-
Monday - February 25, 2008
Bayer invests more than 7 million euros in research center in Aachen, Germany
Cooperation between Bayer MaterialScience, Bayer Technology Services, and RWTH Aachen
-
Monday - November 26, 2007
Bayer CropScience, Mertec and M.S. Technologies to co-develop new soybean trait products
Joint collaboration will bring alternative herbicide tolerant systems and more choice for farmers in weed management
-
Wednesday - October 24, 2007
Nano silver ink developed for ink jet printing:
Electrical wiring diagrams invisible to the naked eye
High conductivity and good adhesion at low curing temperatures / Great potential in the field of printed electronics
-
Wednesday - October 24, 2007
Bayer MaterialScience presents “VisionWorks Award”
Young designers are shaping the future
Students develop ideas for state-of-the-art means of transportation
-
Monday - October 15, 2007
New top-line efficacy data presented from phase II trial of Alemtuzumab in multiple sclerosis:
Three-year analysis demonstrates continued robust treatment effect of Alemtuzumab compared to Rebif®
Search
Publications
Stockholder's Newsletter
Annual Report 2007
Sustainable Development Report 2007
research – The Bayer Scientific Magazine
Publications Overview
Newsletter
Events
Download Center - Selection